1/n It is a dream of any medical oncologist to present at the podium at ASCO. I had that dream realised today to present the first multicentric investigator initiated trial from India.CRSF - Cancer Research and Statistic Foundation Dr (Prof). Vijay Patil Sameer Shrirangwar Nirmal Raut Dr Manuprasad ASCO #ASCO23

💊Triple metronomic chemotherapy is oral and vitally, accessible by pts even in #LMICs ✅This study shows advantage for TMC over NCCN-recommended Rx as 2nd line in Head & Neck cancers Innovative, impactful multicentric study by kothari rushabh Dr (Prof). Vijay Patil and CRSF - Cancer Research and Statistic Foundation team 👏

And that's a wrap for #ASCO23! We are thrilled to witness the unwavering commitment of everyone involved in the fight against cancer. Your dedication is truly inspiring. Shout out to influencers on Day 5: Kimmie Ng, MD, MPH, Oncology Brothers, Julie Gralow, Vivek Subbiah, MD, Samer Al Hadidi, MD,MS,FACP,

My two cents for #match2024 #IMG candidates with regards to creating program lists for them to apply to. Creating a list of program for you to apply to is essentially program research.

For our favourite player of all time, here is a thread on the greatest Eden Hazard moments. I need every Hazard fan to RT this thread for our GOAT.

Let’s look closer at “Impact of Helicobacter Pylori Infection Status on Outcomes among Patients with Advanced Gastric Cancer Treated with Immune Checkpoint Inhibitors” by Monika Laszkowska, MD, MS David Faleck Steve Maron & Yelena Y. Janjigian MD from Memorial Sloan Kettering Cancer Center, recently in #JITC. 1/9

🤩A publication in Lancet - Treatment pattern and outcomes of leptomeningeal carcinomatosis In India doi.org/10.1016/j.lans… Ashish Singh Dr (Prof). Vijay Patil Sameer Shrirangwar Ashay Karpe Bharat Dr Amol Akhade Vanita Noronha, MBBS MD DM Sewanti Limaye 🇮🇳🇺🇸 Umut. Dişel @DrSteveMartin

Unveiling Hope in the Shadows: A Pan-Indian Odyssey through Leptomeningeal Carcinomatosis, where each center becomes a beacon, illuminating the path to better treatments and brighter tomorrows. sciencedirect.com/science/articl… Bharat Vanita Noronha, MBBS MD DM ashayoncology Dr (Prof). Vijay Patil

Prognosis with #leptomeningeal #carcinomatosis is poor with a significant burden of morbidity and mortality in #India. Intrathecal therapy was associated with improved outcomes in patients. Read more 👉bit.ly/49XIlRB

Just a nice case of SMA syndrome with endoscopically confirmed obstruction, treated with a post stenotic, endoscopic through the scope, Nasojejunal tube placement.. With our first year fellow, Ayushi Shah at Upstate Gastroenterology

New RCT in oral cancers! 🔬Phase III trial in borderline resectable advanced oral cancers 💊Cisplatin, 5FU (TP) + Docetaxel with survival benefit vs just TP 😷Sustained survival benefit in patients able to undergo surgery Great work Dr (Prof). Vijay Patil and team! 👏

Super excited to have two submissions accepted for poster presentations and represent SUNY Upstate IM Residency at my first ASCO #ASCO24 ! Grateful to all my faculty and resident mentors Maroun Bou Zerdan, MD Michael Sandhu, MD Dr (Prof). Vijay Patil #Upstate

Poster made it to ASCO but I couldn’t (thanks to United Airlines). Another comprehensive genomic profiling abstract! Cardio-onc manuscript is on its way. As always, special thanks to my mentor Alina Basnet and Dr. Jeffrey Ross SUNY Upstate IM Residency Foundation Medicine (And deevyaparekh!)

💊Does 5-FU dose adjustment for DPYD mutation affect toxicity 🧬118 had no DPYD mutation, 44 heterozygous. 💉5-FU dose adjusted per CPIC guidelines ✅No statistically significant difference in toxicity; CPIC adjustment appropriate for tolerability #ASCO24 SUNY Upstate IM Residency

🫁STK11 mutation in lung adenocarcinoma up from 16 to 20% last 10 years 🧬Reduced association with mutated KRAS, increased with KEAP1 🦀More aggressive cancer, resistance to ICIs hence potentially targetable #ASCO24 SUNY Upstate IM Residency